Literature DB >> 31988490

Outbreak of a novel coronavirus.

Andrea Du Toit1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 31988490      PMCID: PMC7073251          DOI: 10.1038/s41579-020-0332-0

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


× No keyword cloud information.
Since mid-December 2019, several cases of a pneumonia-like disease (with symptoms including fever, difficulty in breathing, cough and invasive lesions on both lungs) of unknown cause have emerged in the central Chinese city of Wuhan (WHO). Chinese authorities made a preliminary determination that the causative agent is a novel coronavirus (2019-nCoV), and other respiratory pathogens have been ruled out as the cause (WHO). A consortium of researchers, government agencies and institutes released six sequences of the coronavirus associated with the outbreak in Wuhan on virological.org and on Global Initiative on Sharing All Influenza Data (GISAID). Phylogenetic analysis indicated that the new virus clusters with the severe acute respiratory syndrome (SARS)-related coronavirus clade, and the virus has since been isolated. So far ~400 confirmed infections with the new coronavirus as well as several deaths have been reported in China (), although scientists at Imperial College in London estimated that the number of cases in Wuhan was likely to be closer to 1,700. In addition, the virus has spread to Thailand, Japan, South Korea and the United States, and additional cases in other countries are likely. Coronaviruses comprise a large family of viruses that cause respiratory and intestinal infections in animals and humans, including Middle East respiratory syndrome (MERS) and SARS. SARS first emerged in the Guangdong province, China, causing the 2002–2003 epidemic. The virus spread rapidly among humans, affecting ~8,000 individuals in more than 30 countries and causing the death of ~800 patients. SARS and MERS coronaviruses likely originated in bats and have been transmitted directly to humans from market civets and dromedary camels. On the basis of initial epidemiological investigations, the pneumonia-like cases in Wuhan have been linked to a seafood and animal market, which might point to a zoonotic origin of the new coronavirus (CDC). The market has since been closed for environmental sanitation and disinfection, and environmental specimens from that and other markets are being collected and tested. The UN health agency has urged China to continue the efforts to identify the source, reservoirs and possible intermediate hosts of the new virus. The Wuhan Health Commission reported that “the possibility of limited human-to-human transmission cannot be ruled out” and infections of the health-care workers as well as infections of family members suggest that person-to-person spread is occurring (). Response measures have been implemented in Wuhan, and ongoing investigations are focussing on understanding the epidemiology, the source, clinical manifestation, transmission routes, global risk assessment and the development of diagnostic tests(Science; WHO).The WHO has called a meeting to decide whether to declare a public-health emergency of international concern (The Washington Post).
  88 in total

1.  Preparedness and Responses of Healthcare Providers to Combat the Spread of COVID-19 Among North Shewa Zone Hospitals, Amhara, Ethiopia, 2020.

Authors:  Getaneh Baye Mulu; Worku Misganaw Kebede; Solomon Adanew Worku; Yohannes Moges Mittiku; Birhanu Ayelign
Journal:  Infect Drug Resist       Date:  2020-09-16       Impact factor: 4.003

Review 2.  COVID-19, cytokines, inflammation, and spices: How are they related?

Authors:  Ajaikumar B Kunnumakkara; Varsha Rana; Dey Parama; Kishore Banik; Sosmitha Girisa; Sahu Henamayee; Krishan Kumar Thakur; Uma Dutta; Prachi Garodia; Subash C Gupta; Bharat B Aggarwal
Journal:  Life Sci       Date:  2021-02-16       Impact factor: 5.037

3.  Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination.

Authors:  Miguel Pereira-Silva; Gaurav Chauhan; Matthew D Shin; Clare Hoskins; Marc J Madou; Sergio O Martinez-Chapa; Nicole F Steinmetz; Francisco Veiga; Ana Cláudia Paiva-Santos
Journal:  Expert Opin Drug Deliv       Date:  2021-06-06       Impact factor: 6.648

4.  Restoration of clean water supply and toilet hygiene reduces infectious diseases in post-disaster evacuation shelters: A multicenter observational study.

Authors:  Tetsuya Akaishi; Kazuma Morino; Yoshikazu Maruyama; Satoru Ishibashi; Shin Takayama; Michiaki Abe; Takeshi Kanno; Yasunori Tadano; Tadashi Ishii
Journal:  Heliyon       Date:  2021-05-14

5.  Efficacy of traditional herbal medicine for psychological sequelae in COVID-19 survivors: A protocol for systematic review and meta-analysis.

Authors:  Eunjin Kim; Jungyoon Choi; Sang Yeon Min; Ji Hwan Kim; Aram Jeong
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 6.  Biobehavioral Aspects of the COVID-19 Pandemic: A Review.

Authors:  Peter A Hall; Paschal Sheeran; Geoffrey T Fong; Charissa S L Cheah; Mark Oremus; Teresa Liu-Ambrose; Mohammad N Sakib; Zahid A Butt; Hasan Ayaz; Narveen Jandu; Plinio P Morita
Journal:  Psychosom Med       Date:  2021-05-01       Impact factor: 4.312

7.  COVID-19 anxiety and quality of life among Iranian nurses.

Authors:  Zohreh Mohamadzadeh Tabrizi; Fatemeh Mohammadzadeh; Arezoo Davarinia Motlagh Quchan; Narjes Bahri
Journal:  BMC Nurs       Date:  2022-01-20

8.  Viral RNA in City Wastewater as a Key Indicator of COVID-19 Recrudescence and Containment Measures Effectiveness.

Authors:  Nathalie Wurtz; Alexandre Lacoste; Priscilla Jardot; Alain Delache; Xavier Fontaine; Maxime Verlande; Alexandre Annessi; Audrey Giraud-Gatineau; Hervé Chaudet; Pierre-Edouard Fournier; Patrick Augier; Bernard La Scola
Journal:  Front Microbiol       Date:  2021-05-17       Impact factor: 5.640

9.  Knowledge, attitude, and associated factors towards COVID-19 among nurses who work in South Gondar Zone, hospitals, Northwest Ethiopia 2020. A multi-central institution-based cross-sectional study.

Authors:  D G Feleke; E S Chanie; B A Tilaye; D Mesfin; B M Birhane; W A Bayih; S F Tassew; S Asnakew; T A Berlie; T Dires; E Dagnaw; T Y Tadesse
Journal:  New Microbes New Infect       Date:  2021-07-03

Review 10.  Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors:  Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.